ORLOFF JOHN J 4
4 · ALEXION PHARMACEUTICALS, INC. · Filed Mar 5, 2019
Insider Transaction Report
Form 4
ORLOFF JOHN J
EVP, Research & Development
Transactions
- Award
Common Stock, par value $.0001 per share
2019-02-28+9,428→ 40,577 total
Footnotes (1)
- [F1]Award of Restricted Stock Units under the 2017 Incentive Plan. 25% vests on each anniversary of the grant date.